secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shockwave Medical, Inc. (—)
CIK:        0001642545
Form:       8-K
Filed at:   2024-05-31T23:59:59+00:00
Accession:  0001193125-24-151730
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 2.04, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shockwave Medical completes $13.1B acquisition by Johnson & Johnson; stockholders get $335/share
--------------------------------------------------------------------------------

- Merger completed May 31, 2024; each share converted to $335 cash, total equity value ~$13.1B.
- Company delisted from Nasdaq; intends to file Form 15 to suspend SEC reporting.
- All directors resigned; CEO Douglas Godshall and CFO Renee Gaeta terminated effective immediately.
- Convertible note holders get $1,293.23 per $1,000 principal if converted during Make-Whole period.
- Credit facility terminated; equity plans and Capped Call Transactions also terminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642545/000119312524151730/0001193125-24-151730-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642545/000119312524151730/d841702d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-151730

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer